Showing results (711-720 of 4,512) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|January 20, 2021
Prognostic value of HMGN family expression in acute myeloid leukemiaWei Cui, Yuna Liu, Yanan Tan, et al.Future Oncology (London, England)|January 22, 2021
Elotuzumab in the treatment of relapsed and refractory multiple myelomaSebastian Grosicki, Martyna Bednarczyk, Agnieszka Barchnicka, et al.Future Oncology (London, England)|November 18, 2021
Concomitant genetic alterations are associated with plasma D-dimer level in patients with non-small-cell lung cancerFangqun Chang, Hao Zhang, Chen Chen, et al.Future Oncology (London, England)|November 10, 2021
Spectrum of lymphoma subtypes based on the latest World Health Organization classification in southern Iran from 2000 to 2011Fatemeh Samiee, Reza Mohammadi, Sadegh Shirian, et al.Future Oncology (London, England)|November 11, 2021
Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?Prajwal Dhakal, Christopher S Wichman, Bunny Pozehl, et al.Future Oncology (London, England)|March 5, 2021
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancerAlberto Zaniboni, Carlo Antonio Barone, Maria Chiara Banzi, et al.Future Oncology (London, England)|January 29, 2021
Luspatercept in the treatment of lower-risk myelodysplastic syndromesOnyee Chan, Rami S KomrokjiFuture Oncology (London, England)|February 3, 2021
Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world studyRuiqi Wang, Guilan Xie, Li Shang, et al.Future Oncology (London, England)|December 16, 2021
CaboPoint: a phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinomaLaurence Albiges, Manuela Schmidinger, Naila Taguieva-Pioger, et al.Future Oncology (London, England)|November 26, 2021
Trastuzumab deruxtecan for HER2+ advanced breast cancerJiyun Lee, Yeon Hee ParkPageof 452